Response and Duration of Serum Anti-SARS-CoV-2 Antibodies After Inactivated Vaccination Within 160 Days
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Response and Duration of Serum Anti-SARS-CoV-2 Antibodies After Inactivated Vaccination Within 160 Days
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-12-23
DOI
10.3389/fimmu.2021.786554
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity
- (2021) Vincent Legros et al. Cellular & Molecular Immunology
- COVID-19 vaccine: where are we now and where should we go?
- (2021) Saman Soleimanpour et al. Expert Review of Vaccines
- Evolution of antibody immunity to SARS-CoV-2
- (2021) Christian Gaebler et al. NATURE
- Looking beyond COVID-19 vaccine phase 3 trials
- (2021) Jerome H. Kim et al. NATURE MEDICINE
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
- (2021) Jennifer M. Dan et al. SCIENCE
- Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission
- (2021) Young-Il Kim et al. Emerging Microbes & Infections
- Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
- (2021) Emma S. Winkler et al. CELL
- Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
- (2021) Adam K. Wheatley et al. Nature Communications
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection
- (2021) Isabella Quinti et al. Frontiers in Cellular and Infection Microbiology
- Incidence of SARS-CoV-2 infection in health care workers from Northern Italy based on antibody status: immune protection from secondary infection- A retrospective observational case-controlled study
- (2021) Francesca Rovida et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- WHO approval of Chinese CoronaVac COVID vaccine will be crucial to curbing pandemic
- (2021) Smriti Mallapaty NATURE
- Systems vaccinology of the BNT162b2 mRNA vaccine in humans
- (2021) Prabhu S. Arunachalam et al. NATURE
- Antibodies against Receptor Binding Domain of SARS-CoV-2 spike protein induced by BNT162b2 vaccine: results from a pragmatic, real-life study
- (2021) Marcello Mariani et al. Journal of Infection and Public Health
- Neutralizing Antibodies Titers and Side Effects in Response to BNT162b2 Vaccine in Healthcare Workers with and without Prior SARS-CoV-2 Infection
- (2021) José Javier Morales-Núñez et al. Vaccines
- Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study
- (2021) Wan Ni Chia et al. Lancet Microbe
- mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern
- (2021) Rishi R. Goel et al. SCIENCE
- Development of an inactivated vaccine candidate for SARS-CoV-2
- (2020) Qiang Gao et al. SCIENCE
- Progress and Prospects on Vaccine Development against SARS-CoV-2
- (2020) Jinyong Zhang et al. Vaccines
- Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
- (2020) Thomas F. Rogers et al. SCIENCE
- Correlates of protection against SARS-CoV-2 in rhesus macaques
- (2020) Katherine McMahan et al. NATURE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
- (2020) Sheila F. Lumley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhanced SARS-CoV-2 neutralization by dimeric IgA
- (2020) Zijun Wang et al. Science Translational Medicine
- IgA dominates the early neutralizing antibody response to SARS-CoV-2
- (2020) Delphine Sterlin et al. Science Translational Medicine
- Long-term protection at 20- to 31-years after primary vaccination with plasma-derived hepatitis B vaccine in a Chinese rural community
- (2019) Jing-Chen Ma et al. Human Vaccines & Immunotherapeutics
- Effectiveness of influenza vaccination on influenza-associated hospitalisations over time among children in Hong Kong: a test-negative case-control study
- (2018) Shuo Feng et al. Lancet Respiratory Medicine
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started